Introduction
Hepatocyte growth factor/Scatter Factor (HGF/SF) is a multipotent growth factor which induces a wide variety of cell events, including mitogenesis, motility and morphogenesis (Gherardi and Stoker, 1991) . All HGF/SFdependent cell events are mediated by the high anity membrane tyrosine kinase receptor Met (Bottaro et al., 1991; Weidner et al., 1993) . HGF/SF-Met signaling usually acts in a paracrine manner, as HGF/SF is produced by mesenchymal cells, while Met is predominantly expressed in the cells derived from epithelial or endothelial origin (Sonnenberg et al., 1993; Stoker et al., 1987) .
Upon HGF/SF binding, Met is tyrosine-phosphorylated and in turn activates its downstream pathways through multiple docking sites within its cytoplasmic domain (Ponzetto et al., 1994) . A number of cytoplasmic signaling molecules or adaptor proteins, such as PI3 kinase (Graziani et al., 1991) , Grb2 (Ponzetto et al., 1994) , Gab1 (Weidner et al., 1996) , Shc (Pelicci et al., 1995) , PLC-g (Ponzetto et al., 1994) , Shp2 phophatase (Fixman et al., 1996) , Src (Faletto et al., 1993; Ponzetto et al., 1994; Rahimi et al., 1998) , Akt (Fan et al., 2000; Xiao et al., 2001) and Stat3 (Boccaccio et al., 1998) , have been reported mediating HGF/SF-Met dependent signal transductions. HGF/SF-Met signaling is essential for embryogenesis, as targeted disruption in mice of either the gene for HGF/SF ligand or the Met receptor leads to embryonic lethality with defects in liver, placenta, skeletal muscle as well as sensory neuron development Maina et al., 1997; Schmidt et al., 1995; Uehara et al., 1995) . HGF/SF also promotes wound healing (Nusrat et al., 1994) , organ regeneration (Matsumoto and Nakamura, 1993) , neural induction (Streit et al., 1995) and angiogenesis (Bussolino et al., 1992; Grant et al., 1993) .
While essential for normal development processes, HGF/SF-Met signaling is frequently implicated in a variety of human cancers. Inappropriate expression of HGF/SF and/or Met has been found in most types of solid tumors including sarcomas, melanomas, carcinomas and gliomas (Cortner et al., 1995; Giordano et al., 1988; Koochekpour et al., 1997; Vande Woude et al., 1997) . Establishment of autocrine HGF/SF-Met signaling in NIH3T3 cells leads to cell transformation and induces tumorigenic and metastatic behavior in nude mice (Rong et al., 1992 (Rong et al., , 1994 . Mutations in c-Met gene have been discovered in human papillary renal cell carcinomas (Schmidt et al., 1997) , gastric cancer (Lee et al., 2000) , metastatic head and neck squamous cell carcinomas (Di Renzo et al., 2000) and childhood hepatocellular carcinoma (Park et al., 1999) . Most mutations have been found in the tyrosine kinase domain of Met and lead to autophosphorylation and constitutive activation of Met, even without HGF/SF stimulation. Moreover, mouse transgenic models using either the Met receptor (Jeers et al., 1998; Wang et al., 2001) or the ligand or mutant of the ligand (Jakubczak et al., 1998; Takayama et al., 1997) are highly cancer prone.
We have been studying the molecular mechanisms and signaling molecules responsible for HGF/SF-Met mediated tumorigenesis and metastasis. The transcription factor Stat3 is a downstream signaling molecule activated by HGF/SF-Met signaling (Boccaccio et al., 1998) and has been reported to contribute to cell transformation induced by a diverse set of oncoproteins (Bowman et al., 2000) . Stat3 is constitutively activated in many primary tumors and tumor cell lines, suggesting that signaling by this molecule is likely to be important for cell transformation. SK-LMS-1, a human cell line established from a leiomyosarcoma, expresses high levels of Met and is highly tumorigenic in athymic nu/nu mice when ectopically expressing HGF/SF (Rong et al., 1993) . In this study, we show that Stat3b, a dominant negative form of Stat3 (Caldenhoven et al., 1996) , has a profound inhibitory eect on HGF/SF-Met mediated growth in soft agar and tumor growth in athymic nu/nu mice, but has no obvious eect on HGF/SF-Met mediated transformed cell morphology, proliferation, invasion or branching morphogenesis.
Results

HGF/SF induces tyrosine phosphorylation and nuclear translocation of Stat3 in SK-LMS-1 cells
The SK-LMS-1 leiomyosarcoma cell line expresses high levels of Met receptor, but only traces of HGF/SF (Rong et al., 1993; Jeers et al., 1996) and with HGF/SF treatment, Met is rapidly tyrosinephosphorylated. SK-LMS-1 cells stably expressing HGF/SF have been established (Jeers et al., 1996) and in these cells, Met is constitutively phosphorylated. HGF/SF induces the tyrosine phosphorylation and nuclear translocation of Stat3 in MDCK epithelial cells (Boccaccio et al., 1998) . Here, we show that HGF/SF has the same eects on Stat3 in SK-LMS-1 leiomyosarcoma cells (Figure 1 ). Stat3 is tyrosine phosphorylated and translocates to the nucleus in serum-starved SK-LMS-1 cells treated with HGF/SF. We tested the eects of expression of a dominantnegative form of Stat3, Stat3b, in the autocrine HGF/ SF-Met SK-LMS-1 cells. Stat3b lacks of the Cterminal transactivation domain of Stat3, is a natural splice variant of Stat3, and functions as a dominant negative regulator of transcription by competing with the Stat3 DNA binding sites (Caldenhoven et al., 1996;  as depicted in Figure 2a ). We isolated independent clones Stat3b A, B, D and C8 stably expressing dierent levels of Stat3b ( Figure 2B ). We tested whether Stat3b overexpression aects the expression or phosphorylation of Met. We prepared cell extracts from the parental and Stat3b expressing clones and subjected them to immunoprecipitation and Western blot analysis using anti-Met antibody. As shown in Figure 2c , overexpression of Stat3b neither aected Met protein level nor its phosphorylation status in these cells.
Stat3b expression inhibits HGF/SF-Met dependent growth of SK-LMS-1 cells in soft agar
Met-expressing cells grow in soft agar in response to HGF/SF (Rahimi et al., 1998) . SK-LMS-1 cells also form colonies in soft agar and display anchorage independent growth in response to HGF/SF (data not shown). Moreover, autocrine HGF/SF-Met signaling promotes anchorage independent growth of these cells 
Stat3b does not inhibit HGF/SF-induced in vitro invasion or branching morphogenesis of SK-LMS-1 cells
SK-LMS-1 cells branch in response to HGF/SF in three-dimensional matrigel (Jeers et al., 1996) . We tested whether Stat3b aects branching morphogenesis of SK-LMS-1 cells. As reported, in the absence of HGF/SF, control parental SK-LMS-1 cells do not branch, while autocrine HGF/SF SK-LMS-1 cells display extensive branching (Figure 5a ). However, no dierences were observed in branching activity between autocrine SK-LMS-1 cells with or without ectopic expression of dominant negative Stat3b (Figure 5a ). The branching morphogenesis activities of autocrine HGF/SF SK-LMS-1 cells and its Stat3b derivatives are, however, HGF/SF-dependent, since HGF/SF neutralizing antibody blocks branching morphogenesis ( Figure 5b ). We also tested the eect of Stat3b on the ability of the parental SK-LMS-1 cells to branch in response to HGF/SF. We generated clones of parental SK-LMS-1 cells stably expressing Stat3b (Figure 6a ). The expression of Stat3b in these clones is higher than that of endogeneous Stat3 (Figure 6a ) and the expression and phosphorylation status of Met receptor in response to HGF/SF shows no obvious dierences between cells with or without Stat3b overexpression (Figure 6b ). SK-LMS-1 cells, with or without Stat3b, display no signi®cant dierences in branching morphogenesis in response to HGF/SF (Figure 6c ). We conclude that SK-LMS-1 cell branching morphogenesis does not require Stat3 activity.
HGF/SF-Met signaling induces invasion of parental SK-LMS-1 cells (Jeers et al., 1996) . To evaluate whether Stat3 activity is required for this phenotype, we performed in vitro invasion assays using matrigel. Dierences in invasion were observed among the clones suggestive of clonal variations (Figure 7a, b) . For example clone 30, expressing the highest level of Stat3b is almost as invasive as the parental SK-LMS-1 cells (Figure 7b ). We conclude that Stat3 does not contribute to the in vitro invasive phenotype of SK-LMS-1 cells.
Stat3b does not affect HGF/SF induced scattering or branching morphogenesis of MDCK cells
We stably introduced Stat3b into MDCK cells ( Figure  8a ) and performed scattering and branching morphogenesis assays. Overexpression of Stat3b neither aected scattering activity (Figure 8b ) nor branching morphogenesis in collagen I gel induced by HGF/SF (Figure 8c ). These data are consistent with the SK-LMS-1 cell data and imply that Stat3 is not required for the HGF/SF-Met induced branching morphogenesis, motolity or invasion.
Stat3b inhibits HGF/SF-Met signaling mediated in vivo tumorigenicity
SK-LMS-1 cells autocrine for HGF/SF are highly tumorigenic and metastatic in athymic nu/nu mice (Jeers et al., 1996) . We asked whether Stat3b aects the in vivo tumorigenicity of the stable autocrine SK-LMS-1 overexpressing Stat3b. While the autocrine cells lacking Stat3b expression grew to 2 mm in diameter in 3 ± 4 weeks and to a diameter of 20 mm by 6 weeks, the SK-LMS-1 cells overexpressing Stat3b failed to develop tumors (Figure 9 ). Out of the twelve injected animals, one animal developed a 2 mm mass by week 3, however this failed to grow further and disappeared during the course of the experiment (Figure 9) . A second animal developed a 2 mm tumor by week 6. The tumor continued to grow and on examination, Stat3b expression in this tumor was lost (data not shown). These results demonstrated that Stat3, as for many other oncogenes is absolutely required for the HGF/SF-Met mediated tumorigenesis.
Discussion
Aberrant HGF/SF-Met signaling has been associated with the malignant process of many solid tumors, and multiple downstream pathways induced by the HGF/SF have been implicated in proliferation, motility and invasion, and anchorage independent growth in vitro, as well as tumorigenesis and metastasis in vivo. Stat3b has no obvious eect on HGF/SF induced cell morphology changes, proliferation, invasion or branching morphogenesis, but is required for anchorage independent growth and tumorigenesis. Is Stat3b aecting pathways other than Stat3? No other target of Stat3b has been reported, but even if it does, the speci®c blocking of anchorage independent growth and tumorigenesis is quite remarkable and it should be possible to identify an alternative pathway(s).
Inappropriate and constitutive activation of Stat3 has been shown to be responsible for malignant tumor progression and is actuated by a diverse set of (Besser et al., 1999; Bromberg et al., 1998; Turkson et al., 1998; Zong et al., 1998) . Stat3 functions as a transcription factor which regulates the expressions of target genes, such as cMyc, Bcl-x L , p21 WAF1/CIP1 and cyclin D1 (Bowman et al., 2000; Bromberg and Darnell, 2000) . Suppression of Stat3 function by Stat3b inhibits anchorage independent growth and tumorigenesis mediated by HGF/SF-Met signaling ( Figures 3, 4 and 9 ). Stat3b-mediated inhibition of tumorigenesis is not due to any eect on cell proliferation because hgf/sf-transfected SK-LMS-1 cells with and without overexpression of Stat3b showed similar mitogenic activities as determined by 3 Hthymidine incorporation assay (data not shown). Previously, Stat3b has been shown to suppress B16 melanoma tumor growth that leads to tumor cell apoptosis (Niu et al., 1999) . We found that overexpression of Stat3b in autocrine SK-LMS-1 cells down-regulates the expression of Bcl-x L , but ectopic expression of Bcl-x L does not restore growth in soft agar (data not shown).
Stat3b has no obvious eect on in vitro invasion or branching morphogenesis of SK-LMS-1 human leiomyosarcoma cells (Figures 5 and 6 ) nor on MDCK cell branching morphogenesis (Figure 8 ). Expressing activated R-Ras in MDCK epithelial cells promotes branching tubulogenesis in collagen gel, but does not stimulate anchorage-independent growth in soft agar (Khwaja et al., 1998) and, constitutively activated Ron, a tyrosine kinase receptor structurally related to Met but with distinct activities, induces branching tubulogenesis but not growth in soft agar (Santoro et al., 1996) . Both anchorage independent growth and branching morphogenesis are complex processes and therefore, it is not surprised that cells may require dierent combinations of activated pathways and/or quantitative dierences in gene expressions to achieve such dierent cellular responses. However, a report that induction of epithelial branching tubulogenesis by HGF/SF depends on Stat3 pathway (Boccaccio et al., 1998) is not con®rmed in our studies. Perhaps the dierence is explained by the dierent approaches to inhibit Stat3 signaling. Moreover, we show that dominant negative Stat3b had no eect on cell motility induced by HGF/SF-Met. However, it is reported that Stat3 is essential for keratinocyte cell migration (Sano et al., 1999) .
The link between HGF/SF-Met signaling and Stat3 may be direct and/or indirect. The evidence for a direct link is that Stat3 associates with the multiple docking sites of Met and thereby is activated upon HGF/SF stimulation (Boccaccio et al., 1998) . However, Stat3 may also act through the c-Src kinase that can be phosphorylated and activated by HGF/SF-Met signaling (Faletto et al., 1993; Ponzetto et al., 1994; Rahimi et al., 1998) . Src family kinases play very important role in Stat signaling (Reddy et al., 2000) . Stat3 is constitutively activated in v-Src transformed cells, and it is conceivable that HGF/SF-Met signaling may activate Stat3 through activation of c-Src kinase. Indeed, c-Src kinase activity is required for HGF/SF-induced anchorage-independent growth of mammary carcinoma cells (Rahimi et al., 1998) . Another possible way that activation can occur is through Rac GTPase. Rac is activated by and required for HGF/SF-Met induced cell spreading and dissociation in MDCK cells (Redley et al., 1995; Royal et al., 2000) , although the mechanism is unclear. Importantly, dominant negative Rac1 also has been shown to inhibit the anchorage independent growth induced by the Tpr-Met in soft agar (Rodrigues et al., 1997) . In Src transformation, Rac1-mediated JNK signaling is required for Stat3 serine phosphorylation and transcriptional activity induced by Src (Turkson et al., 1999) . To achieve a full transcriptional activation of Stat3, not only tyrosine (705) phosphorylation and nuclear translocation must occur, but phosphorylation of serine (727) is required (Decker and Kovarik, 2000) . Serine (727) phosphorylation can be stimulated by the MAPK and/or the JNK pathway (Decker and Kovarik, 2000) both of which are activated by HGF/SF-Met signaling (Rodrigues et al., 1997) . In fact, activation of JNK pathway is essential for the Tpr-Met oncogene induced transformation (Rodrigues et al., 1997) . Thus, multiple pathways activated by HGF/SF-Met signaling may involve cellular transformation by converging on Stat3 and leading to a fully transcriptional active form of Stat3. A defect(s) which fails to induce full activation of Stat3 may interfere with anchorage independent growth and tumorigenicity. Therefore, targeting the Stat3 pathway may provide a way to intervene in HGF/SF-Met mediated oncogenesis and tumor progression.
Materials and methods
Cell lines
The SK-LMS-1 human leiomyosarcoma cell line was obtained from American Type Culture Collection and cultured in Dullbecco's modi®ed Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS). The hgf/ sf-transfected SK-LMS-1 stable cell line has been described (Jeers et al., 1996) . MDCK epithelial cell line was cultured in DMEM supplemented with 5% FBS.
Expression plasmids, transfection and establishment of stable cell lines
The Stat3b expression vector pSG5hStat3b has been described previously (Caldenhoven et al., 1996) . Transfection was performed using FuGENE 6 transfection reagent (Roche). Brie¯y, cells plated in a 6-well dish were cotransfected with 1.9 mg of pSG5hStat3b and 0.1 mg of pSV2neo plasmid (Southern and Berg, 1982) carrying neomycin resistant gene or 0.1 mg of pCEP4 plasmid (Invitrogen) carrying hygromycin resistant gene. Forty-eight hours after transfection, cells were subjected to G418 (800 mg/ ml; Gibco) or Hygromycin B (400 mg/ml; Gibco) selection. Two weeks later, individual clones were picked and screened for stable transfectants.
Western blot analysis
Cells growing in 6-well plates were collected in 100 ml of 16Laemmli sample buer (Sigma), and boiled for 10 min. Ten ml of cell extracts were resolved by 10% SDS ± PAGE. The proteins were then electrotransferred onto a PVDF membrane (Invitrogen). After being blocked for 1 h with 5% of dry milk in TBS buer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1% Tween-20), blots were probed for 1 h at room temperature or overnight at 48C by the following primary antibodies: anti-Stat3 (F-2; Santa Cruz), anti-Phospho-Stat3 (Tyr705) (New England BioLabs), anti-h-Met (C-28; Santa Cruz) or anti-Phosphotyrosine (clone 4G10; Upstate Biotechnology). Then, blots were reacted with peroxidaseconjugated antibody for 1 h followed by visualizing the proteins using ECL detection reagents (Amersham).
Immunoprecipitation
Cells growing in a 10 cm dish were extracted by 1 ml of lysis buer consisting of 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP 40, 0.5% Deoxycholate, 0.1% SDS, 1 mM EDTA pH 8.0, 50 mM NaF, 1 mM Sodium Orthovanadate and supplemented with Proteinase Inhibitor Cocktail Tablets (Roche). Cell lysates were rotated at 48C for 15 min followed by centrifuge at 15 000 g for 15 min at 48C. After being quanti®ed by DC protein assay (Bio-Rad), 0.5 mg of cell extracts was reacted with 10 ml of anti-h-Met (C-28) antibody overnight at 48C. Immune complexes were collected on protein A-agarose beads (Life Technologies) and washed three times using the same buer. Immune complexes were eluted in 26Laemmli sample buer (Sigma) and boiled for 5 min before being resolved by SDS ± PAGE. Western blot analyses were performed as described above.
Immunofluorescence
Cells were grown on a Lab-Tek Chamber Slide (Nalge Nunc International). After serum starved for 16 h, cells were treated with 200 units/ml of HGF/SF in DMEM containing 1 mg/ml of bovine serum albumin (BSA). Thirty minutes after HGF/SF treatment, cells were ®xed in 3.7% formaldehyde in phosphate buer saline (PBS). Cells were permeabilized in 0.1% Nonidet P-40 for 10 min, blocked with 5% goat serum and 1% BSA in PBS for 1 h, and incubated with antiStat3 (F2) antibody for 1 h. Cells were stained with Texas Red-labeled secondary antibody (Molecular Probes, Netherland), visualized and photographed under an immuno¯uor-escence microscope.
Colony formation assay
Cells were suspended in DMEM containing 10% FBS and 0.5% SeaPlaque agarose (FMC BioProducts), and poured onto a 60 mm dish containing a semi-solid layer of 0.5% SeaPlaque agarose in DMEM supplemented with 10% FBS. Cells were fed weekly with DMEM containing 10% FBS and 0.5% SeaPlaque agarose. After 2 weeks growing in soft agar, colonies were counted and representative ®elds were photographed under a phase contrast microscope.
Branching morphogenesis assay
Branching morphogenesis assay for SK-LMS-1 cells was performed as described previously (Jeers et al., 1996) . For MDCK cells, type I collagen gel was used for this assay. Brie¯y, 10 000 cells of MDCK were suspended in 100 ml of collagen gel solution containing eight parts of Collagen I (rat tail, 3.05 mg/ml, Becton Dickinson), one part of 106DMEM and one part of 0.5 M HEPES (pH 7.4) and plated in a 96-well dish. After gelling at 378C for 20 min, 100 ml of DMEM-5% FBS with or without 100 units/ml of HGF/SF was added to each well. Cells were incubated at 378C in 5% CO 2 and re-fed with new medium every 2 days. Six days after incubation, cells were observed under a confocal microscope and representative ®elds were photographed. 
In vitro invasion assay
The in vitro invasion assay was performed as previously described (Jeers et al., 1996) using a 24-well size Invasion Chamber coated with Growth factor reduced Matrigel (Becton Dickinson).
Scattering assay
MDCK cells (5000 cells per well), were seeded onto 96-well plate and cultured for 12 h in 100 ml of DMEM and 5% FBS, with or without 10 Units/ml of HGF/SF. At the end of experiment, cells were stained with 0.2% Crystal Violet in 70% ethanol for 10 min and photographed.
In vivo tumorigenicity assay Four-week old female athymic nude mice (Ncr nu/nu; Animal Production Area, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD, USA) were used for this assay. 1610 5 cells were suspended in 100 ml of Hanks' Balanced Salt Solution (Life Technologies) and injected subcutaneously into the back of each mouse. Tumors were measured twice a week.
